Sigyn Therapeutics ( (SIGY) ) has released a notification of late filing.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Sigyn Therapeutics, Inc. has announced a delay in filing its Form 10-K (Yearly Report) for the financial period ending December 31, 2024. The delay is primarily due to time constraints related to the compilation, dissemination, and review of the necessary information, which made timely filing impractical without undue hardship and expense. The company has committed to filing the report no later than fifteen days after the original due date. There are no anticipated significant changes in financial results from the previous fiscal year, and the company continues to ensure compliance with all other filing requirements. The notification was signed by James Joyce, the Chief Executive Officer.
More about Sigyn Therapeutics
YTD Price Performance: 25.40%
Average Trading Volume: 493
Technical Sentiment Signal: Buy
Current Market Cap: $6.34M
Learn more about SIGY stock on TipRanks’ Stock Analysis page.